Induction treatment in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: a systematic review and meta-analysis

BACKGROUND AND AIM: High-grade B cell lymphomas with concomitant MYC and BCL2 and/or BCL6 rearrangements (HGBCL-DH/TH) have a poor prognosis when treated with the standard R-CHOP-like chemoimmunotherapy protocol. Whether this can be improved using intensified regimens is still under debate. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeremski, Vanja, Kropf, Siegfried, Koehler, Michael, Gebauer, Niklas, McPhail, Ellen D., Habermann, Thomas, Schieppati, Francesca, Mougiakakos, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399221/
https://www.ncbi.nlm.nih.gov/pubmed/37546419
http://dx.doi.org/10.3389/fonc.2023.1188478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399221/
https://www.ncbi.nlm.nih.gov/pubmed/37546419
http://dx.doi.org/10.3389/fonc.2023.1188478

Ejemplares similares